Tourmaline Bio, Inc. (TRML)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Sandeep C. Kulkarni M.D. | Co-Founder, CEO & Director | 848.25k | -- | 1982 |
| Mr. Ryan Robinson CPA | CFO & Treasurer | 575.86k | -- | 1989 |
| Mr. W. Bradford Middlekauff J.D. | Chief Business Officer, General Counsel & Corporate Secretary | 582.25k | -- | 1962 |
| Dr. Susan Dana Jones Ph.D. | Chief Technology Officer | -- | -- | 1961 |
| Ms. Kimberly Piorkowski | Vice President of People, Culture & Compliance | -- | -- | -- |
| Dr. Kevin B. Johnson M.B.A., Ph.D. | Chief Regulatory Officer | 555.84k | -- | 1965 |
| Ms. Dora Rau | Senior VP & Head of Quality | -- | -- | -- |
| Mr. Gerhard Hagn Pharm.D. | Senior VP and Head of Commercial & Business Development | -- | -- | -- |
| Dr. Emil M. deGoma M.D. | Senior Vice President of Medical Research | -- | -- | -- |
| Dr. Kristine Erickson O.D., Ph.D. | VP & TA Head of Ophthalmology, Medical Research | -- | -- | -- |
Tourmaline Bio, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 74
Description
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York.
Corporate Governance
Upcoming Events
August 6, 2025 at 12:30 PM UTC - August 11, 2025 at 12:30 PM UTC
Tourmaline Bio, Inc. Earnings Date
Recent Events
November 12, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission